JOHNNA BREIER: Open Payments
NPI 1174197263 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,620 in 77 payments from 14 companies in 2025. Trend: 2023 $1,517 · 2024 $1,561 · 2025 $2,620
Food & beverage: $2,620
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 21 | $781 |
| ABBVIE INC. | 16 | $730 |
| UCB, Inc. | 8 | $278 |
| Novartis Pharmaceuticals Corporation | 6 | $178 |
| GlaxoSmithKline, LLC. | 6 | $171 |
| PFIZER INC. | 8 | $163 |
| Fresenius Kabi USA, LLC | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Alexion Pharmaceuticals, Inc. | 2 | $48 |
| Pharmacosmos Therapeutics Inc. | 1 | $41 |
Products named: RINVOQ, UPLIZNA, Bimzelx, EVENITY, BENLYSTA, XELJANZ, SKYRIZI, TAVNEOS.
Industry payments across NY — which companies pay providers there.
